These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6675189)

  • 21. Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts.
    Raimondo G; Smedile A; Gallo L; Balbo A; Ponzetto A; Rizzetto M
    Lancet; 1982 Jan; 1(8266):249-51. PubMed ID: 6120275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The delta agent: HBsAg particles with delta antigen and RNA in the serum of an HBV carrier.
    Bonino F; Hoyer B; Ford E; Shih JW; Purcell RH; Gerin JL
    Hepatology; 1981; 1(2):127-31. PubMed ID: 6169614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Delta infection in HBsAg carriers].
    Hess G; Slusarczyk J; Hansson BG; Dienes HP; Baumann W; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1984 Dec; 22(12):692-6. PubMed ID: 6396986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hepatitis B and the delta agent].
    Jilg W; Roggendorf M; Zoulek G; Schlipköter U; Deinhardt F
    Fortschr Med; 1984 Feb; 102(6):119-21. PubMed ID: 6706267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Delta virus superinfection in a patient with chronic viral hepatitis B].
    Decker T; Baumgarten R; Roschlau G
    Zentralbl Allg Pathol; 1986; 132(4):283-8. PubMed ID: 3541449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fulminant B viral hepatitis: role of delta agent.
    Govindarajan S; Chin KP; Redeker AG; Peters RL
    Gastroenterology; 1984 Jun; 86(6):1417-20. PubMed ID: 6714570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Delta hepatitis in Switzerland. Determination of delta antigens and delta antibodies in 397 HBsAg-positive patients (1978-1984)].
    Burkhardt F; Schilt U
    Schweiz Med Wochenschr; 1984 Jul; 114(30):1042-6. PubMed ID: 6474132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of antibody to the hepatitis delta virus in symptomless HBsAg carriers.
    Arico S; Aragona M; Rizzetto M; Caredda F; Zanetti A; Marinucci G; Diana S; Farci P; Arnone M; Caporaso N
    Lancet; 1985 Aug; 2(8451):356-8. PubMed ID: 2862515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delta agent infection in Melbourne.
    Hoy JF; Hansson BG; Dimitrakakis M; Gust I; Lucas CR
    J Med Virol; 1984; 13(4):339-45. PubMed ID: 6736942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fulminant delta hepatitis in chronic asymptomatic HBsAg carriers.
    Tassopoulos N; Roumeliotou-Karayannis A; Nakopoulou L; Calafatas P; Papaevangelou G
    JAMA; 1985 Apr; 253(16):2362-3. PubMed ID: 3981762
    [No Abstract]   [Full Text] [Related]  

  • 31. Long term follow up of chronic hepatitis B virus infection in intravenous drug abusers and homosexual men.
    Moestrup T; Hansson BG; Widell A; Nordenfelt E; Hägerstrand I
    Br Med J (Clin Res Ed); 1986 Mar; 292(6524):854-7. PubMed ID: 3083909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exacerbation of chronic liver disease due to hepatitis B surface antigen after delta infection.
    Raimondo G; Longo G; Squadrito G
    Br Med J (Clin Res Ed); 1983 Mar; 286(6368):845. PubMed ID: 6403109
    [No Abstract]   [Full Text] [Related]  

  • 33. Epidemiology and clinical course of delta infection in Britain.
    Lok AS; Farci P; Thomas HC
    Prog Clin Biol Res; 1983; 143():219-23. PubMed ID: 6669576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fulminant delta hepatitis in chronic hepatitis B infection.
    De Cock KM; Govindarajan S; Redeker AG
    JAMA; 1984 Nov; 252(19):2746-8. PubMed ID: 6387205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of serum anti-delta with intrahepatic HBV and HDV antigens in patients with chronic active hepatitis.
    Caporaso N; Di Sapio M; Del Vecchio-Blanco C; Coltorti M
    Prog Clin Biol Res; 1987; 234():137-44. PubMed ID: 3628372
    [No Abstract]   [Full Text] [Related]  

  • 36. Exacerbation of chronic liver disease due to hepatitis B surface antigen after delta infection.
    Shattock AG; Fielding JF
    Br Med J (Clin Res Ed); 1983 Apr; 286(6373):1279-80. PubMed ID: 6404423
    [No Abstract]   [Full Text] [Related]  

  • 37. Delta agent infection in patients with chronic liver diseases and hepatocellular carcinoma--an infrequent finding in Taiwan.
    Chen DS; Lai MY; Sung JL
    Hepatology; 1984; 4(3):502-3. PubMed ID: 6327488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of delta infection on severity of hepatitis B.
    Smedile A; Farci P; Verme G; Caredda F; Cargnel A; Caporaso N; Dentico P; Trepo C; Opolon P; Gimson A; Vergani D; Williams R; Rizzetto M
    Lancet; 1982 Oct; 2(8305):945-7. PubMed ID: 6127458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delta hepatitis in inapparent carriers of hepatitis B surface antigen. A disease simulating acute hepatitis B progressive to chronicity.
    Farci P; Smedile A; Lavarini C; Piantino P; Crivelli O; Caporaso N; Toti M; Bonino F; Rizzetto M
    Gastroenterology; 1983 Sep; 85(3):669-73. PubMed ID: 6873613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and significance of antibodies to delta antigen in hepatitis B virus infection.
    Rizzetto M; Shih JW; Gocke DJ; Purcell RH; Verme G; Gerin JL
    Lancet; 1979 Nov; 2(8150):986-90. PubMed ID: 91776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.